Dr. Yi Lin

Anesthesiology
535 E 70th St, 
New York, NY 
535 E 70th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Yi Lin is an Anesthesiologist in New York, New York. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Lung Nodules. His top areas of expertise are Smoldering Multiple Myeloma, Primary Mediastinal B-Cell Lymphoma (PMBCL), Relapsed Refractory Multiple Myeloma (RRMM), Knee Replacement, and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 908 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Anesthesiology
Licenses
Anesthesiology in NY
Hospital Affiliations
Hospital For Special Surgery
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Hospital for Special Surgery
535 E 70th St, New York, NY 10021

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase II Study of IRD (Ixazomib, Lenalidomide, & Dexamethasone) for Consolidation Therapy Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
A Phase II Study of IRD (Ixazomib, Lenalidomide, & Dexamethasone) for Consolidation Therapy Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: November 07, 2025
Intervention Type: Drug, Biological
Study Drugs: Ixazomib, Lenalidomide, Dexamethasone
Study Phase: Phase 2
Phase I/II Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation and Anti-PD-1 Antibody (Pembrolizumab) for Patients With Non-Hodgkin Lymphoma
Phase I/II Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation and Anti-PD-1 Antibody (Pembrolizumab) for Patients With Non-Hodgkin Lymphoma
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Other, Procedure, Biological
Study Drugs: Dendritic Cell Therapy, Pembrolizumab, Pneumococcal 13-Valent Conjugate Vaccine
Study Phase: Phase 1/Phase 2
A Phase 1/2 Multicenter Study Evaluating the Safety and Efficacy of KTE-C19 in Adults With Refractory Aggressive Non-Hodgkin Lymphoma
A Phase 1/2 Multicenter Study Evaluating the Safety and Efficacy of KTE-C19 in Adults With Refractory Aggressive Non-Hodgkin Lymphoma
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Biological, Drug
Study Drugs: Axicabtagene Ciloleucel, Fludarabine, Cyclophosphamide
Study Phase: Phase 1/Phase 2
Phase 2 Trial of Pembrolizumab, Ixazomib, and Dexamethasone for Relapsed Multiple Myeloma
Phase 2 Trial of Pembrolizumab, Ixazomib, and Dexamethasone for Relapsed Multiple Myeloma
Enrollment Status: Completed
Publish Date: January 09, 2024
Intervention Type: Drug, Other, Biological
Study Drugs: Dexamethasone, Ixazomib Citrate, Pembrolizumab
Study Phase: Phase 2
The Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Total Knee Replacement
The Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Total Knee Replacement
Enrollment Status: Completed
Publish Date: March 25, 2020
Intervention Type: Drug
Study Phase: Phase 4
Phase II Study of LCL161 Alone and in Combination With Cyclophosphamide in Patients With Relapsed or Refractory Multiple Myeloma
Phase II Study of LCL161 Alone and in Combination With Cyclophosphamide in Patients With Relapsed or Refractory Multiple Myeloma
Enrollment Status: Completed
Publish Date: September 10, 2019
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase 2 Open Label Study to Investigate the Safety and Clinical Activity of Autologous EBV-specific T Cells (CMD-003) for the Treatment of Patients With EBV Positive Lymphomas
A Phase 2 Open Label Study to Investigate the Safety and Clinical Activity of Autologous EBV-specific T Cells (CMD-003) for the Treatment of Patients With EBV Positive Lymphomas
Enrollment Status: Terminated
Publish Date: March 26, 2019
Intervention Type: Biological
Study Phase: Phase 2
A Phase 2 Single Arm Study to Investigate the Efficacy of Autologous EBV-specific T-cells for the Treatment of Patients With Aggressive EBV Positive Extranodal NK/T-cell Lymphoma (ENKTCL)
A Phase 2 Single Arm Study to Investigate the Efficacy of Autologous EBV-specific T-cells for the Treatment of Patients With Aggressive EBV Positive Extranodal NK/T-cell Lymphoma (ENKTCL)
Enrollment Status: Terminated
Publish Date: March 13, 2019
Intervention Type: Biological
Study Phase: Phase 2
View 7 Less Clinical Trials

908 Total Publications

Synergy Assessment of Pollution and Carbon Reduction and Prediction of Carbon Peaking at the City Scale: A Case Study of Shaoxing City, Zhejiang Province
Synergy Assessment of Pollution and Carbon Reduction and Prediction of Carbon Peaking at the City Scale: A Case Study of Shaoxing City, Zhejiang Province
Journal: Huan jing ke xue= Huanjing kexue
Published: November 29, 2025
Similar Doctors
Advanced in Lung Nodules
Dr. Wei Yu
Anesthesiology
Advanced in Lung Nodules
Dr. Wei Yu
Anesthesiology

Woodhull Medical And Mental Health Center

760 Broadway, 
Brooklyn, NY 
 (4.6 miles away)
718-963-8496
Languages Spoken:
English
See accepted insurances

Wei Yu is an Anesthesiologist in Brooklyn, New York. Dr. Yu is rated as a Distinguished provider by MediFind in the treatment of Lung Nodules. His top areas of expertise are Fractured Spine, Upper Tract Urothelial Carcinoma (UTUC), Camurati-Engelmann Disease, Prostatectomy, and Endoscopy.

Mary Lee
Experienced in Lung Nodules
Dr. Mary Lee
Anesthesiology
Experienced in Lung Nodules
Dr. Mary Lee
Anesthesiology

Long Island Jewish Medical Center

27005 76th Ave, 
New Hyde Park, NY 
 (12.9 miles away)
718-470-7390
Languages Spoken:
English
See accepted insurances

Mary Lee is an Anesthesiologist in New Hyde Park, New York. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Lung Nodules. Her top areas of expertise are Lung Nodules, Mediastinal Tumor, and Lymphofollicular Hyperplasia.

Experienced in Lung Nodules
Dr. Dawn Desiderio
Anesthesiology
Experienced in Lung Nodules
Dr. Dawn Desiderio
Anesthesiology

Memorial Sloan Kettering Cancer Center

1275 York Ave, 
New York, NY 
 (0.2 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances

Dawn Desiderio is an Anesthesiologist in New York, New York. Dr. Desiderio is rated as an Experienced provider by MediFind in the treatment of Lung Nodules. Her top areas of expertise are Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lin's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile